openPR Logo
Press release

Male Hypogonadism Market is expected to grow at the highest CAGR and dominance over the analysis period

03-20-2019 07:31 AM CET | Health & Medicine

Press release from: Allied Market Research

Male Hypogonadism Market

Male Hypogonadism Market

According to Allied Market Research's report on the Male Hypogonadism Market, the global market size is estimated at $ 2,594 million and will reach $ 323 million by 2022, an annual average growth of 3.1% from 2016 to 2022 It's possible. The pituitary disease sector is expected to account for nearly half of the total market share in 2015 and is expected to maintain market dominance over the analysis period.

Hypogonadism in the male is a clinical condition in which the testes fail to produce sufficient testosterone, resulting in decreased development of muscle mass, loss of body hair growth, development of breast tissue and a lack of vocalization. Growth in the male hypogonadism market is due to increased prevalence and frequency of patients with testosterone deficiency, increased rates of infertility, and increased patient awareness of options for treating STDs according to certain campaigns conducted by governments. In addition, the risk of germs is very high in the elderly population and in obese and diabetic populations.

The increase in the elderly population and the occurrence of chronic lifestyle disorders (obesity and diabetes) are expected to further stimulate market growth. However, the high side effects of all testosterone products are expected to hamper the growth of the testosterone replacement therapy (TRT) segment in this market. Technology advancement is expected to provide new opportunities during the forecast period.

Download PDF Report Sample @

Key players have adopted product approval as their key strategy to cater to the changing needs of the industry. There is high competition among key players to launch innovative, technologically advanced products to increase their market share and serve the patients in a better way. Major players operating in this market include AbbVie Inc., Allergan plc, AstraZeneca plc, Bayer AG, Eli Lilly and Company Ltd., Endo International plc, Merck & Co., Inc., Ferring Holding S.A., Finox Biotech, IBSA Institut Biochimque SA, Laboratoires Genevrier, and Teva Pharmaceutical Industries Ltd.

North America accounted for the majority of market share (more than three quarters) in 2015 and is expected to dominate throughout the forecast period. This is due to an increase in the population suffering from primary and secondary causes of hypogonadism and an increase in patient awareness of the usefulness of treatment options. The high adoption rate of high technology products and the presence of highly sophisticated medical infrastructure are expected to create new growth opportunities for key players in this market. Europe is expected to register the highest CAGR of 7.2% during the analysis period with an increase in the adoption of western lifestyle, an increase in unhealthy eating habits, and an increase in the population with hypogonadism. Growth of urbanization.

Make an Enquiry before Buy @

Key Findings of the Male Hypogonadism Market
• By drug therapy, gonadotropin and gonadotropin-releasing hormones therapy segment is projected to grow at the highest CAGR of 8.9% during the forecast period.
• Pituitary disorders segment is expected to grow at the CAGR of 3.2%.
• Injectables accounted for nearly half of the market share in 2015.
• North America accounted for majority of the share (more than three-fourths) in 2015, and is expected to remain dominant throughout the forecast period.
• U.S. accounted for the majority share in the North American market in 2015, and the Mexican market is expected to grow at the highest CAGR of 6.7%.

Access Full Summery @

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.


David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Male Hypogonadism Market is expected to grow at the highest CAGR and dominance over the analysis period here

News-ID: 1663611 • Views: 184

More Releases from Allied Market Research

Remittance Market Statistics - 2021: Market Share, Current Trends, Global Market …
The major purpose of remittance is to ensure security of the money during money transfer from one country to another. In addition, many financial institutions across the globe have adopted remittance services to provide customer with transparency, a richer and data-driven ecosystem, and an efficient network of partners. Moreover, increase in cross-border transactions, mobile-based payment channels, and reduced remittance cost & transfer time drive the growth of the market. Allied
LiDAR Market Assessment, Global Opportunity and Forecast till 2028 | Faro Techno …
Light detection and ranging (LiDAR) devices are used for capturing high-resolution 3D or 2D data of geospatial surfaces. LiDAR is an emerging technology that helps to capture high-definition 3D data of geospatial surfaces. Innovations in the laser technology help to bring price corrections in LiDAR products. Simultaneously, changes in demands and preferences of the urban population unveil newer LiDAR applications apart from conventional military applications. The sophistication of 3D imaging
Domain Name System Service Market CAGR Analysis, Demand, Growth Factors, and Lea …
The domain name system service (DNS) is a naming database application that translates and locates internet domain names into internet protocol addresses.The DNS service is used by web browsing and many other internet activities to provide users with the information they need to connect to a remote host. DNS mapping is distributed throughout the internet in a hierarchy of authority. It is used for resolving names of World Wide Web
Document Capture Software Market Report with Emerging Trends, Highlights and Cha …
Document capture software isa process ofscanning and uploading paper documents to an electronic repository.It is automatically identifies document types such as purchase orders, invoices, checks, packing slips, bills of lading, purchase requisition forms, business-specific documents, and receipts. In addition, document capture software has several advantages such as it helps manufacturers to maximizes asset utilization, improve product quality, reduce time to market, and eliminates paper records.. Adoption of document capture software

All 5 Releases

More Releases for Hypogonadism

Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism …
The report "Global Market Study on Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism during 2017 - 2026 ", has been prepared based on an in-depth market analysis with inputs from industry experts. Male hypogonadism is a condition in males wherein the testes depict a significantly reduced functioning level than normal. Reduction in rate of biosynthesis of the male sex hormones consequently results into male hypogonadism, which can
Male Hypogonadism Market Growth Contemplation By 2025
Global Male Hypogonadism Market: Snapshot Hypogonadism in males refers to a condition in the male body where the testes show a significantly reduced level of functioning than normal. The overall result of male hypogonadism is a reduction in the rate of biosynthesis of male sex hormones. This state is more commonly known as interrupted stage 1 puberty. Hypoandrogenism, or the low androgen or testosterone level in a male can vary in
Male Hypogonadism Market Poised to Reach $ 3,300 Mn by 2026
North America will continue to dominate the global male hypogonadism market, with more than one-third revenue share during the forecast period. In addition, revenues from the male hypogonadism market in North America will exhibit the fastest expansion through 2026, as compared to those from all the other regional segments comprised in the report. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative for the male hypogonadism market.
Male Hypogonadism Market Growth Bar Increases $3,233 Million In 2022
Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice. For More Info, Get Sample : The global male hypogonadism market was valued at $2,594 million in
Male Hypogonadism - Pipeline Review, H1 2017 has announced the addition of the “Male Hypogonadism - Pipeline Review, H1 20172017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann
Male Hypogonadism - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Male Hypogonadism - Pipeline Review, H2 2017”. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Request For Sample Report@ Risk factors for hypogonadism include HIV/AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles and